27 Apr YAZ PLUS (DROSPIRENONE 3,0 mg ETHINYLESTRADIOL 0,02 mg LEVOMEFOLATE CALCIUM 0,451 mg)
|
Company name & Address: |
Registration number |
Batch number(s) |
Expiry date |
Pack size |
First distributed |
Re-call Classification |
Recall date |
Date Published |
| Bayer (Pty) Ltd, 27 Wrench Road Isando, 1600, South Africa |
45/21.8.2/0534 |
WEW96J |
March 2026 |
28’s |
9 & 24 November 2023 |
Class II Type A |
19 November 2024 |
21 November 2024 |
Brief description of the problem (reason for recall)
This recall is initiated due to a limited number of packs found in retail Pharmacy, with mix-up of the sequence of hormone-containing and hormone-free tablets, wherein some packs had • 24 light orange hormone-free, and • 4 pink film-coated hormone tablets Instead of • 24 pink film-coated hormone tablets and • 4 light orange hormone-free tablets.
Advice for health professionals and distributors
Please return all stocks of this batch to DSV Healthcare or the wholesaler/distributor that you purchased it from, for credit.
Proposed action taken and its urgency: A SAHPRA approved recall letter was distributed to all distribution points and the recall process was initiated.
Reporting side effects
Public and healthcare professionals are encouraged to report any side effects after using a health product or after immunisation by using the Med Safety App. Your report will contribute to our monitoring of these health products.